# DAPTOMYCIN
> **NDA217630** · New Drug Application · Sponsor: MAIA PHARMS INC · Approved 2024-11-21
## Drug
- **FDA Application Number:** NDA217630
- **Application type:** New Drug Application
- **Brand name:** DAPTOMYCIN
- **Generic name:** DAPTOMYCIN
- **Active ingredients:** DAPTOMYCIN
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** MAIA PHARMS INC
- **Manufacturer:** Par Health USA, LLC
- **First approval:** 2024-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217630)
---
*MORVS · CC0 1.0*